Neurostimulation devices are revolutionizing the brain health devices market by offering innovative treatment options for various neurological conditions. These devices use electrical or magnetic stimulation to modulate brain activity and alleviate symptoms associated with conditions such as Parkinson's disease, epilepsy, depression, and chronic pain.
The global brain health devices market was valued at US$ 9,070.5 million in 2018, and is expected to witness a CAGR of 7.7% during the forecast period (2019–2026).
Deep brain stimulation (DBS) is one of the most well-known neurostimulation techniques. In DBS, electrodes are implanted into specific regions of the brain, and electrical impulses are delivered to regulate abnormal neural activity. This therapy has shown significant success in managing motor symptoms in Parkinson's disease patients and has also been explored for treating other movement disorders and psychiatric conditions.
Transcranial magnetic stimulation (TMS) is another neurostimulation technique gaining popularity. TMS devices use magnetic fields to stimulate specific areas of the brain non-invasively. It has been approved for the treatment of depression and has shown promising results in clinical trials for conditions like migraine, obsessive-compulsive disorder, and post-traumatic stress disorder. TMS offers a non-pharmacological alternative and has a favorable safety profile compared to traditional treatments.
Furthermore, emerging technologies such as transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) are being investigated for their potential therapeutic benefits. These techniques involve delivering low-intensity electrical currents to the scalp to modulate brain activity and enhance cognitive functions. They have shown promise in areas such as cognitive enhancement, stroke rehabilitation, and the treatment of neuropsychiatric disorders.
Neurostimulation devices are not only providing effective treatment options but are also evolving to offer personalized and adaptive stimulation. Advanced devices integrate closed-loop systems that monitor brain activity in real-time and adjust stimulation parameters accordingly. This closed-loop approach ensures precise and tailored therapy, optimizing treatment outcomes and minimizing side effects.
As research and development in neurostimulation continue to progress, the brain health devices market is expected to witness significant growth. The ongoing exploration of new stimulation targets, advancements in device design, and the integration of artificial intelligence are all contributing to the rapid evolution of neurostimulation devices, revolutionizing the field of brain health and neurological care.
Global Pharmaceutical Excipients Market, by Function (Binder, Lubricant, Filler, Coating), By Application (Oral, Parenteral, Topical), By Product (Organic Chemicals, Inorganic Chemicals) - Global Forecast 2027Pharmaceutical Excipients Market HighlightsPharmaceutical excipients are substances formulated for the efficient and effective administration of medicines to patients facilitating drug absorption.
Market Research Future (MRFR)’s assessment asserts that the global pharmaceutical excipients market is projected to strike a moderate CAGR during the review period 2016 to 2027.The growth of the pharmaceutical industry in conjunction with the investments injected for the development of new drugs is anticipated to catapult the pharmaceutical excipients market on an upward trajectory.
In addition, the research & development for the formulation of better excipients is also projected to favor the growth pace of the market over the next couple of years.An upsurge in demand for excipients is expected with the rapid developments in oncological medications.
Also, the patent expirations of popular drugs are also prognosticated to fuel the growth of the pharmaceutical excipients market over the next few years.Key players are focusing on the development of multi-functional excipients.
The growing demand for these excipients is poised to have a favorable impact on the proliferation of the pharmaceutical excipients market across the projection period.The rising burden of diseases such as cancer, tuberculosis, etc.
Thus, the future trajectory of the pharmaceutical excipients market is anticipated to remain lucrative for the next few years.Market Segmentation:By product, the global pharmaceutical excipients market has been bifurcated into organic chemicals and inorganic chemicals.By function, the pharmaceutical excipients market has been segmented into fillers, coatings, binders, disintegrants, lubricants & glidants, preservatives, and others.By application, the global pharmaceutical excipients market has been segmented into topical, oral, parenteral, and advanced delivery system.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/868Regional Analysis:By region, the global pharmaceutical excipients market has been segmented into North America, Europe, Asia, and the Rest of the World (RoW).
